Pancreatic Cancer Research

ResearcherBrooke Army Medical CenterActive in the last 2 years

Elizabeth L. Carpenter

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4036-7715; OpenAlex author ID A5043749842. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 7

  1. Localized Pancreatic Cancer among Military Beneficiaries: A National Cancer Database Analysis. Co-author DOI 10.1093/milmed/usaf465↗
  2. Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. Co-author DOI 10.1002/jso.27466↗
  3. The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy. Co-author DOI 10.1002/jso.27689↗
  4. Impact of Mediating and Confounding Variables on the Volume-Outcome Association in the Treatment of Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12908-z↗
  5. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-023-13758-z↗
  6. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. Co-author DOI 10.1245/s10434-022-11800-0↗
  7. ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma. First author DOI 10.1245/s10434-022-11878-6↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel William Nelson · 6 shared papers, 2022–2024 · strength 1.10
  2. Timothy J. Vreeland · 6 shared papers, 2022–2024 · strength 1.10
  3. Alexandra M. Adams · 5 shared papers, 2022–2024 · strength 0.88
  4. Anne E. O’Shea · 4 shared papers, 2022–2024 · strength 0.73
  5. Phillip M. Kemp Bohan · 4 shared papers, 2022–2024 · strength 0.69
  6. Robert Connor Chick · 3 shared papers, 2022–2026 · strength 0.62
  7. Patrick M. McCarthy · 3 shared papers, 2022–2024 · strength 0.50
  8. Robert W. Krell · 2 shared papers, 2022–2026 · strength 0.44
  9. Holly V. Spitzer · 2 shared papers, 2023 · strength 0.37
  10. Franklin A. Valdera · 2 shared papers, 2024 · strength 0.36
  11. Joal D. Beane · 1 shared paper, 2026 · strength 0.30
  12. Patrick W. Underwood · 1 shared paper, 2026 · strength 0.30
  13. Jordan M. Cloyd · 1 shared paper, 2026 · strength 0.30
  14. Timothy Michael Pawlik · 1 shared paper, 2026 · strength 0.30
  15. Timothy Eric Newhook · 1 shared paper, 2024 · strength 0.19
  16. Matthew H. G. Katz · 1 shared paper, 2023 · strength 0.18
  17. Ching-Wei David Tzeng · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.